BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
-7.1%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.6B
AUM Growth
-$327M
(-11%)
Cap. Flow
-$87.4M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
46.85%
Holding
189
New
9
Increased
66
Reduced
46
Closed
16
Top Buys
| 1 |
Wells Fargo
WFC
|
+$16.1M |
| 2 |
Amazon
AMZN
|
+$15.4M |
| 3 |
Danaher
DHR
|
+$15.1M |
| 4 |
PepsiCo
PEP
|
+$15M |
| 5 |
Johnson Controls International
JCI
|
+$14.5M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$47.2M |
| 2 |
Salesforce
CRM
|
+$37.9M |
| 3 |
EOG Resources
EOG
|
+$21.4M |
| 4 |
Johnson & Johnson
JNJ
|
+$16.5M |
| 5 |
McDonald's
MCD
|
+$14M |
Sector Composition
| 1 | Healthcare | 24.6% |
| 2 | Technology | 18.79% |
| 3 | Consumer Discretionary | 14.05% |
| 4 | Communication Services | 13.96% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
TJX Companies
TJX
$155B
| $485K | 0.02% |
8,002
-1,736
| -18% | -$105K |
|
127
Castle Biosciences
CSTL
$621M
| $481K | 0.02% |
10,724
+1,035
| +11% | +$46.4K |
|
128
Iovance Biotherapeutics
IOVA
$821M
| $464K | 0.02% |
27,882
+2,893
| +12% | +$48.1K |
|
129
Apellis Pharmaceuticals
APLS
$3.14B
| $461K | 0.02% |
9,069
+2,734
| +43% | +$139K |
|
130
Trane Technologies
TT
$89.2B
| $454K | 0.02% |
2,971
-42
| -1% | -$6.42K |
|
131
Workday
WDAY
$59.6B
| $445K | 0.02% |
1,858
| – | – |
|
132
Chevron
CVX
$317B
| $412K | 0.02% |
2,529
| – | – |
|
133
Shell
SHEL
$207B
| $401K | 0.02% |
+7,300
| New | +$401K |
|
134
iShares Core US Aggregate Bond ETF
AGG
$132B
| $383K | 0.01% |
3,572
| – | – |
|
135
Etsy
ETSY
$5.84B
| $381K | 0.01% |
3,067
| – | – |
|
136
Arrowhead Research
ARWR
$4.11B
| $377K | 0.01% |
8,203
+808
| +11% | +$37.1K |
|
137
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $377K | 0.01% |
4,832
| – | – |
|
138
SPDR S&P Biotech ETF
XBI
$5.43B
| $357K | 0.01% |
3,974
-15
| -0.4% | -$1.35K |
|
139
Citigroup
C
$183B
| $341K | 0.01% |
6,376
-47,542
| -88% | -$2.54M |
|
140
DaVita
DVA
$9.52B
| $339K | 0.01% |
3,000
| – | – |
|
141
Perrigo
PRGO
$3.06B
| $332K | 0.01% |
8,650
| – | – |
|
142
Netflix
NFLX
$505B
| $330K | 0.01% |
880
| – | – |
|
143
Xylem
XYL
$34.5B
| $328K | 0.01% |
3,846
-2,249
| -37% | -$192K |
|
144
10x Genomics
TXG
$1.57B
| $322K | 0.01% |
4,234
+428
| +11% | +$32.6K |
|
145
Blackstone
BX
$142B
| $304K | 0.01% |
2,398
+298
| +14% | +$37.8K |
|
146
CRISPR Therapeutics
CRSP
$5.12B
| $284K | 0.01% |
4,519
+443
| +11% | +$27.8K |
|
147
Oracle
ORCL
$821B
| $284K | 0.01% |
3,433
| – | – |
|
148
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $268K | 0.01% |
2,212
| – | – |
|
149
iShares MSCI India ETF
INDA
$9.38B
| $263K | 0.01% |
+5,912
| New | +$263K |
|
150
iShares MSCI Japan ETF
EWJ
$15.7B
| $261K | 0.01% |
4,231
| – | – |
|